Sudokof Syrup 100ml

Description

Sudokof

Antitussive Syrup

Presentation

Sokof Antilussive Syrup. Each 5 ml syrup contains Dextromethorphan HBr BP 20 mg. Phenylephrine HCI BP 10 mg & Triprolidine HCI BP 2.5 mg.

Description

Sudokof Antitussive syrup is a mixture of antitussive, decongestant and antihistamine agents.

Dextromethorphan is used to suppress dry cough. Dextromethorphan is safe, effective and non-narcotic

antitussive. It blocks the cough reflex in situations where the dry cough serves no purpose. It does so by

calming the cough centre of the brain that governs the coughing reflex. Dextromethorphan does not induce tolerance, and has no potential for addiction like opiates Phenylephrine acts by stimulating alpha-adrenergic receptors. Phenylephrine acts on receptors in the muscles of the blood vessel walls, causing them to contract. This results in narrowing of the blood vessels and decreased blood flow in the lining of the nose and sinuses. Thus fluid congestion in the nose and

sinuses is reduced. Triprolidine is a strong antihistamine, which acts on histamine-1 (H) receptor. It blocks histamine, preventing dilatation of blood vessels, reducing redness and swelling It may

drowsiness.

Indications and Uses

the action of

cause mild

Sudokof, the combination of Dextromethorphan, Phenylephrine & Triprolidine is used to relieve the

symptoms of colds and flu, runny nose, nasal congestion and cough, where these are associated with dry

cough Dosage and Administration

Age

Dose

Adults and Children over 12 years

1 teaspoonful (5 ml) 4 times in a day

6-12 years of age

½ teaspoonful (2.5 mi) 4 times in a day

Side effects

Few side effects to be associated with this medicine are known such as rash, disturbed sleep, drowsiness disturbances of the gut such as danhoes, constipation, nausea, vomiting or abdominal pain, dry mouth, nose and throat are occasionally reported

Contraindication This combination is contraindicated in patients with a known hypersensitivity to Dextromethorphan

Phenylephrine or Triprolidine Contraindicated in persons under treatment with monoamine oxidase

inhibitors within 2 weeks of stopping such treatment. It is contraindicated in patients with severe

hypertension or severe coronary artery disease.

Precaution

The combination preparation may cause drowsiness and impair performance in tests of auditory vigilance

It may also impair the patients’ ability to drive and also to use machineries. Although there are no objective data, users of this syrup should avoid the concomitant use of alcohol or other centrally acting sedatives. Although Phenylephrine has virtually no blood pressure effect in patients with normal blood pressure, this combination should be used with caution in patients taking antihypertensive agents, tricyclic antidepressants or other sympathomimetic agents such as decongestant, appetite suppressants and amphetamine like psychostimulants. As with other sympathomimetic agents caution should be excercised in patients with hypertension, heart disease, diabetes, hyperthyroidism, elevated intraocular pressure and prostatic enlargement. This combination should not be used for persistent or chronic cough that occurs with smoking, asthma, or emphysema or where cough is accompanied by excessive secretion unless directed

by a physician

Use in Pregnancy and Lactation Pregnancy There is no information regarding safety of this medicine in pregnancy. So it must be consulted

with doctor before using in pregnancy

Lactation: The effect of this medicine on the breastfed baby is unknown, therefore this medicine should be

used with caution in breastfeeding mothers.

Storage conditions

Store at cool & dry place. Protect from light. Keep out of the reach of the children

Commercial pack

Sudokof Antitussive Syrup: Each box contains an amber color PET

measuring cup

Manufactured by

Incepta Pharmaceuticals Ltd

Savar, Dhaka, Bangladesh Trademark